BikeRaceInfo: Current and historical race results, plus interviews, bikes, travel, and cycling history

find us on Facebook follow us on twitter See our youtube channel Tour de France: The Inside Story Neugent Cycling Wheels Cycle Italia cycling tours Cycles BiKyle Schwab Cycles South Salem Cycleworks vintage parts Advertise with us!

Search our site:
Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Email Newsletter

Bicycle Racing News and Opinion,
Tuesday, May 8, 2018

Back to news and opinion index page for links to archived stories | Commentary | Our YouTube page
2018 Tour de France | 2018 Giro d'Italia

It is forbidden to kill; therefore all murderers are punished unless they kill in large numbers and to the sound of trumpets. - Voltaire

Current racing:

Upcoming Racing:

Latest completed racing:


It was a relatively quiet day in cycling as the Giro transferred to Sicily for Tuesday's stage four. But there was one important development in pro cycling:

Chris Froome hoping medical study will discredit drug test

This story appeared in the Irish Times:

Chris Froome’s battle to rescue his reputation after a failed drugs test looks bound for the court of arbitration for sport as it emerged that a study calling into question the efficacy of the test will form a key part of his defence.

The 32-year-old is competing in the Giro d’Italia with Team Sky as he bids to win a historic third successive Grand Tour. He won last year’s Tour de France and the Vuelta a España.

Chris Froome

Chris Froome riding the 2018 Giro stage one time trial.

In December The Guardian and Le Monde revealed a urine test submitted after stage 18 of the Vuelta showed excessive levels of the asthma drug salbutamol, and Froome could yet be stripped of that title if he is found to have committed an anti-doping violation.

In terms of Froome’s legacy, what happens on the roads in Italy over the next 2½ weeks of the Giro could be secondary to the recent publication of a study entitled “Futility of current urine salbutamol doping control”.

The report, published in the British Journal of Clinical Pharmacology, claims it is not feasible to determine a dosage level of salbutamol based on the results of a single “untimed” urine sample.

You can read the entire story here.

Back to news and opinion index page for links to archived stories | Commentary